TD Waterhouse Canada’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$792 Hold
142
﹤0.01% 2118
2025
Q4
$200 Hold
142
﹤0.01% 1942
2025
Q3
$362 Hold
142
﹤0.01% 1948
2025
Q2
$288 Hold
142
﹤0.01% 1874
2025
Q1
$329 Hold
142
﹤0.01% 1820
2024
Q4
$236 Hold
142
﹤0.01% 1856
2024
Q3
$638 Hold
142
﹤0.01% 1735
2024
Q2
$596 Hold
142
﹤0.01% 1766
2024
Q1
$611 Hold
142
﹤0.01% 1758
2023
Q4
$655 Sell
142
-1
-0.7% -$4 ﹤0.01% 1586
2023
Q3
$665 Hold
143
﹤0.01% 1578
2023
Q2
$800 Hold
143
﹤0.01% 1620
2023
Q1
$970 Hold
143
﹤0.01% 1599
2022
Q4
$2K Hold
143
﹤0.01% 1482
2022
Q3
$1.1K Hold
143
﹤0.01% 1572
2022
Q2
$1.56K Hold
143
﹤0.01% 1567
2022
Q1
$2.94K Hold
143
﹤0.01% 1539
2021
Q4
$5.73K Buy
+143
New +$6.84K ﹤0.01% 1434

Other funds holding EDSA

TD Waterhouse Canada's EDSA Position: Q1 2026 in Review

TD Waterhouse Canada held its Edesa Biotech (EDSA) position steady in Q1 2026 at 142 shares worth $792. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

TD Waterhouse Canada first reported a position in EDSA in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.73K in Q4 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

  • TD Waterhouse Canada held 142 shares of Edesa Biotech worth $792 as of Q1 2026.
  • TD Waterhouse Canada left its Edesa Biotech share count unchanged in Q1 2026.
  • Edesa Biotech made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2118 holding.
  • TD Waterhouse Canada first reported a position in Edesa Biotech in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Edesa Biotech position peaked at $5.73K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.